Tirzepatide shows powerful diabetes-prevention effect in three-year trial

Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the results of a new study.

from Top Health News -- ScienceDaily https://ift.tt/JtvU8qB